SCHEMBL6661513

SCHEMBL6661513

Cn1cnc2c(Sc3ccccc3)ncnc21

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC29A1 Q99808 1/20 0.49
CDK1 P06493 1/20 0.49
ADORA1 P30542 2/20 0.47
ADORA2A P29274 1/20 0.47
YTHDC1 Q96MU7 1/20 0.45
ALDH1A1 P00352 2/20 0.42
HPGD P15428 2/20 0.42
LMNA P02545 2/20 0.42
MAPT P10636 2/20 0.42
SMN1; SMN2 Q16637 2/20 0.42
NPC1 O15118 2/20 0.42
RAB9A P51151 2/20 0.42
CYP1A2 P05177 3/20 0.42
CYP3A4 P08684 1/20 0.38
CYP2D6 P10635 1/20 0.38
PKM P14618 1/20 0.38
NFKB1 P19838 1/20 0.38
THPO P40225 1/20 0.38
PMP22 Q01453 1/20 0.38
TSHR P16473 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6663342 0.85 ADORA1 (0.45) SLC29A1CDK1ADORA1ADORA2AYTHDC1
SCHEMBL6666246 0.78 CYP1A2 (0.68) SLC29A1CDK1ALDH1A1HPGDLMNA
SCHEMBL31060284 0.77 ADORA2A (0.62) SLC29A1ADORA2AALDH1A1HPGDCYP1A2
SCHEMBL6662063 0.77 ADORA2A (0.62) SLC29A1ADORA2AALDH1A1HPGDCYP1A2
SCHEMBL6426384 0.76 CYP1A2 (0.59) CDK1ADORA1ADORA2AYTHDC1SMN1; SMN2
SCHEMBL6666272 0.75 ADORA2A (0.51) SLC29A1ADORA1ADORA2AALDH1A1HPGD
SCHEMBL6660016 0.74 ADORA3 (0.62) ADORA1ADORA2AALDH1A1HPGDLMNA
SCHEMBL6662718 0.72 CDK1 (0.52) CDK1ADORA1ADORA2AYTHDC1NPC1
SCHEMBL29842526 0.72 CDK1 (0.52) CDK1ADORA1ADORA2AYTHDC1NPC1
SCHEMBL754946 0.72 ADORA1 (0.51) CDK1ADORA1ADORA2AYTHDC1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1444982-A1 The use of purine derivatives as selective kinase inhibitors MERCKLE GMBH (DE) 2004-08-11 EP disclosed